Adaptimmune Therapeutics Plc (ADAP) Insider Trading
- $80,274,368.40
- $25,072,315.08
- Sept. 1, 2023
- Adrian Rawcliffe
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 1, 2023 | CEO | 2,403 | $0.78 | Sell | $1,874.34 | |
Aug. 1, 2023 | Insider | 3,096 | $0.91 | Sell | $2,817.36 | |
July 10, 2023 | Director | 47,702 | $0.91 | Sell | $43,408.82 | |
June 27, 2023 | CEO | 2,333 | $0.92 | Sell | $2,146.36 | |
Jan. 31, 2023 | Insider | 11,890 | $1.87 | Sell | $22,234.30 | |
Jan. 17, 2023 | CEO | 10,057 | $1.86 | Sell | $18,706.02 | |
Jan. 17, 2023 | Insider | 4,440 | $1.86 | Sell | $8,258.40 | |
Jan. 12, 2023 | COO | 4,973 | $1.71 | Sell | $8,503.83 | |
Jan. 12, 2023 | CEO | 18,763 | $1.71 | Sell | $32,084.73 | |
Jan. 11, 2023 | Insider | 3,843 | $1.75 | Sell | $6,725.25 | |
Jan. 4, 2023 | CEO | 5,073 | $1.69 | Sell | $8,573.37 | |
Jan. 4, 2023 | Insider | 1,100 | $1.69 | Sell | $1,859.00 | |
Jan. 4, 2023 | COO | 3,584 | $1.69 | Sell | $6,056.96 | |
Sept. 1, 2022 | CEO | 2,536 | $1.97 | Sell | $4,995.92 | |
Aug. 1, 2022 | Insider | 2,983 | $1.77 | Sell | $5,279.91 | |
July 5, 2022 | Insider | 1,973 | $1.68 | Sell | $3,314.64 | |
June 27, 2022 | CEO | 2,562 | $1.63 | Sell | $4,176.06 | |
May 20, 2022 | CFO | 39,000 | $0.29 | Buy | $11,310.00 | |
Jan. 18, 2022 | Insider | 2,121 | $3.19 | Sell | $6,765.99 | |
Jan. 18, 2022 | CEO | 11,096 | $3.19 | Sell | $35,396.24 | |
Jan. 18, 2022 | COO | 4,368 | $3.19 | Sell | $13,933.92 | |
Jan. 12, 2022 | Insider | 1,076 | $3.54 | Sell | $3,809.04 | |
Jan. 11, 2022 | COO | 3,770 | $3.56 | Sell | $13,421.20 | |
Jan. 11, 2022 | CEO | 14,362 | $3.56 | Sell | $51,128.72 | |
Jan. 4, 2022 | COO | 3,490 | $4.06 | Sell | $14,169.40 | |
Jan. 4, 2022 | CEO | 5,532 | $4.06 | Sell | $22,459.92 | |
Jan. 4, 2022 | Insider | 1,070 | $4.06 | Sell | $4,344.20 | |
Sept. 1, 2021 | CEO | 2,782 | $5.20 | Sell | $14,466.40 | |
Aug. 2, 2021 | Insider | 2,939 | $3.58 | Sell | $10,521.62 | |
June 28, 2021 | CEO | 2,794 | $4.37 | Sell | $12,209.78 | |
Jan. 19, 2021 | Insider | 2,111 | $5.67 | Sell | $11,969.37 | |
Jan. 19, 2021 | CEO | 9,879 | $5.67 | Sell | $56,013.93 | |
Jan. 12, 2021 | CEO | 2,707 | $6.15 | Sell | $16,648.05 | |
Jan. 12, 2021 | COO | 2,234 | $6.15 | Sell | $13,739.10 | |
Jan. 12, 2021 | Insider | 1,058 | $6.15 | Sell | $6,506.70 | |
Jan. 4, 2021 | COO | 3,499 | $5.33 | Sell | $18,649.67 | |
Jan. 4, 2021 | Insider | 1,065 | $5.33 | Sell | $5,676.45 | |
Jan. 4, 2021 | CEO | 4,967 | $5.33 | Sell | $26,474.11 | |
Dec. 14, 2020 | COO | 207,000 | $0.69 | Buy | $142,830.00 | |
Dec. 14, 2020 | CFO | 24,000 | $0.69 | Buy | $16,560.00 | |
Sept. 1, 2020 | CEO | 2,776 | $8.51 | Sell | $23,623.76 | |
Aug. 3, 2020 | CEO | 2,788 | $9.25 | Sell | $25,789.00 | |
Aug. 3, 2020 | Insider | 4,823 | $9.25 | Sell | $44,612.75 | |
June 29, 2020 | CFO | 33,000 | $1.62 | Buy | $53,460.00 | |
June 9, 2020 | Director | 12,900 | $1.89 | Buy | $24,381.00 | |
May 29, 2020 | Director | 500,000 | $9.33 | Sell | $4,665,000.00 | |
Jan. 24, 2020 | Major Shareholder | 7,500,000 | $0.67 | Buy | $5,025,000.00 | |
Jan. 14, 2020 | CEO | 3,236 | $5.13 | Sell | $16,600.68 | |
Jan. 14, 2020 | COO | 2,397 | $5.13 | Sell | $12,296.61 | |
Jan. 14, 2020 | Insider | 911 | $5.13 | Sell | $4,673.43 |
Insiders are both buying and selling Adaptimmune Therapeutics Plc stock.
The insider traders at Adaptimmune Therapeutics Plc are: Adrian Rawcliffe, John Lunger, William C. Bertrand, Jr., William C Bertrand Jr, Orbimed Advisors Llc, Enterprise Associates 14 New, Peter A Thompson, Gavin Wood, Gwendolyn Knowlt Binder-Scholl, Elliot Norry, James Noble, Charles Elliott Sigal, David M Mott, Lawrence M. Alleva, Rafael Amado, Ali Behbahani, Garry E Menzel, Peter W Sonsini, Ravi Viswanathan, and Cintia Piccina
The most active insider trader at Adaptimmune Therapeutics Plc is Adrian Rawcliffe with 21 trades.
Orbimed Advisors Llc has sold the most Adaptimmune Therapeutics Plc stock with a total value of $14,870,124.50.
Ali Behbahani has bought the most Adaptimmune Therapeutics Plc stock with a total value of $40,080,000.00.
The most recent insider trade for Adaptimmune Therapeutics Plc was on Sept. 1, 2023.
The single biggest insider buy for Adaptimmune Therapeutics Plc was from Ali Behbahani with a total value of $20,040,000.00 on Sept. 7, 2018.
The single biggest insider sell for Adaptimmune Therapeutics Plc was from Orbimed Advisors Llc with a total value of $12,052,770.50 on March 29, 2018.